Publication | Closed Access

Zoledronic Acid Effectively Prevents Aromatase Inhibitor–Associated Bone Loss in Postmenopausal Women with Early Breast Cancer Receiving Adjuvant Letrozole: Z-FAST Study 36-Month Follow-up Results

Bone DiseaseBreast OncologyBone HealthOncologyMedicineGynecologyAromataseBreast CancerMenopausePharmacotherapyPharmacologyOsteoporosisEndocrine-related CancerPostmenopausal Women